期刊文献+

Inhibition of Differentiation by Transforming Growth Factor β1 in Rhabdomyosarcoma Cells

Inhibition of Differentiation by Transforming Growth Factor β1 in Rhabdomyosarcoma Cells
下载PDF
导出
摘要 OBJECTIVE To study the effect of transforming growth factor β1 (TGF-β1) on differentiation of rhabdomyosarcoma (RMS) cells METHODS RD (human embryonal RMS cell line) cells, cultured in differentiation medium containing 9-cis retinoic acid (9CRA), were treated with TGF-β1. Proliferation of the cells was examined by the MTT assay. The differentiation specific proteins (sarcomeric actin and MyHC) and myogenic transcription factors (MyoD1 and myogenin) in the RD cells were assessed by immunofluorescence staining. RESULTS Compared to control cells, treatment with lower concentrations of TGF-β1 (0.1 and 0.2 ng/ml) induced an increase in OD values after 4 d (P〈0.01), whereas higher concentrations of TGF-β1 (2 and 5 ng/ml) led to a reduction of cell viability (P〈0.01). After exposure to 9CRA, the viability of the cells decreased significantly (P〈0.01), while sarcomeric actin, MyHC and myogenin were induced. These changes were antagonized by TGF-β1 (0.1 ng/ml). No changes were observed in expression of MyoD1. CONCLUSION The RMS cells, derived from myogenic progenitors are committed to a myogenic fate, but are arrested in the differentiation course by the addition of TGF-β1 which represses some of the myogenic transcription factors. OBJECTIVE To study the effect of transforming growth factor?1 (TGF-β1)on differentiation of rhabdomyosarcoma(RMS)cells METHODS RD(human embryonal RMS cell line)cells,cultured in differentiation medium containing 9-cis retinoic acid(9CRA),were treated with TGF-β1.Proliferation of the cells was examined by the MTT assay.The differentiation specific proteins(sarcomeric actin and MyHC)and myogenic transcription factors(MyoD1 and myogenin)in the RD cel s were assessed by immunofluorescence staining. RESULTS Compared to control cel s,treatment with lower concentrations of TGF-?1(0.1 and 0.2 ng/ml)induced an increase in OD values after 4 d(P<0.01),whereas higher concentrations of TGF-?1(2 and 5 ng/ml)led to a reduction of cell viability(P<0.01).After exposure to 9CRA,the viability of the cells decreased significantly(P<0.01),while sarcomeric actin,MyHC and myogenin were induced.These changes were antagonized by TGF-β1(0.1 ng/ml).No changes were observed in expression of MyoD1. CONCLUSION The RMS cells,derived from myogenic progenitors are committed to a myogenic fate,but are arrested in the differentiation course by the addition of TGF-?1 which represses some of the myogenic transcription factors.
出处 《Chinese Journal of Clinical Oncology》 CSCD 2007年第5期327-332,共6页 中国肿瘤临床(英文版)
基金 the grants fromthe Jiangshu Provincial Higher InstitutionNatural Science Foundation(No.2134605) Soochow Universtiy Medicine DevelopmentFoundation(No.EE134513) the Ji-angshu Provincial Post-Doctoral Foundation(No.51208).
关键词 TGF-Β1 PROLIFERATION DIFFERENTIATION rhabdomyosarcoma. 横纹肌肉瘤 癌症 治疗方法 转变模式
  • 相关文献

参考文献11

  • 1YELü,ZHANGHong-ying,WANGHua,YANGGuang-hua,BUHong,ZHANGLi,WANGShou-li.Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD[J].Chinese Medical Journal,2005(8):678-686. 被引量:7
  • 2Levy L,Hill CS.Alterations in components of theTGF-?superfamily signaling pathways in human can-cer[].Cytokine and Growth Factor Reviews.2006
  • 3SpornMB,RobertsAB.TGF-β:Problemsandpros-pects[].Cell Regulation.1990
  • 4Liu D,,Black BL,Derynck R.TGF-beta inhibits muscledifferentiationthroughfunctionalrepressionofmyo-genictranscriptionfactorsbySmad3[].Genesis.2001
  • 5DiasP,PharhamDM,ShapiroDN,etel.Myogenicreg-ulatoryprotein(MyoD1)expressioninchildhoodsolidtumors:Diagnosticutilityinrhabdomyosarcoma[].American Journal of Pathology.1991
  • 6Jason WB,Joe CW,Marieke M,et al.Differentiation ofrhabdomyosarcomacelllinesusingretinoicacid[].Pe-diatrBloodCancer.2006
  • 7StevensMCG.Treatmentforchildhoodrhabdomyosar-coma:the cost of cure[].The Lancet Oncology.2005
  • 8RicaudS,VernusB,DuclosM,atal.Inhibitionofau-tocrinesecretionofmyostatinenhancesterminaldif-ferentiationinhumanrhabdomyosarcomacells[].Oncegene.2003
  • 9Okuno M,Kojima S,Matsushima-Nishiwaki R,et al.RetinoidsinCancerChemopreventionCurrent[].CancerDrug Targets.2004
  • 10HamadeA,DeriesM,BegemannG,etal.Retinoicacidactivates myogenesis in vivo through Fgf8 signalling[].Developmental Biology.2006

二级参考文献10

  • 1XieL,LawBK,AakreME,etal.Transforminggrowthfactorbeta regulatedgeneexpressioninamousemammaryglandepithelialcellline[].BreastCancerRes.2003
  • 2WangH,YangGH,BuH.TheexpressionofTGF β1andTGF βreceptorsinhumanrhambdomyosarcoma[].JClinExpPathol(Chin).2002
  • 3ReynisdottirJ,MassagueJ.Thesubcellularlocationsofp15INK4Bandp27Kip1 coordinatetheirinhibitoryinteractionswithcdk4andcdk2[].Genes and Development.1997
  • 4GrandoriC,EisenmanR.MyctargetgenesTrends[].BiochemSci.1997
  • 5HenrikssonM,LuscherB.Proteinsofthemycnetwork: essentialregulatiorsofcellgrowthanddifferentiation[].AdvCancer.1996
  • 6IavaroneA,MassagueJ.RepressionoftheCDKactivatorCdc25Aandcell cyclearrestbycytokineTGF βincellslackingtheCDKinhibitorP15[].Nature.1997
  • 7MalliriA,YeudallWA,NikolicM, etal.Sensitivitytotransforminggrowthfactorbeta1inducedgrowtharrestiscommoninhumansquamouscellcarcinomacelllines: c mycdownregulationandP21Waf1inductionareimportantearlyevents[].CellGrowthDiffer.1996
  • 8RaoP,KadeschT.Theintracellularformofnotchblockstransforminggrowthfactorbeta mediatedgrowtharrestinMv1Luepithelialcells[].Molecular and Cellular Biology.2003
  • 9KimAH,LebmanDA,DietzCM, etal.Transforminggrowthfactor betaisanendogenousradioresistancefactorintheesophagealadenocarcinomacelllineOE 33[].International Journal of Oncology.2003
  • 10LiC,SuardetL,LittleJB.PotentialroleofWAF/Cip/p21asamediatorofTGF βcytoinhibitoryeffect[].Journal of Biochemistry.1995

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部